• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年男性局限性前列腺癌的管理:高龄和合并症的意义。

Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.

机构信息

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Semin Radiat Oncol. 2012 Oct;22(4):284-94. doi: 10.1016/j.semradonc.2012.05.005.

DOI:10.1016/j.semradonc.2012.05.005
PMID:22985811
Abstract

The majority of men diagnosed with prostate cancer are diagnosed later in life. Although localized prostate cancer is often an indolent disease, older men are more frequently diagnosed with high-risk disease and are more likely to die from prostate cancer than younger men. Comorbid medical conditions are also more prevalent in the later decades of life and can impact prostate cancer treatment tolerance and the likelihood of benefiting from aggressive cancer treatment. Older men diagnosed with prostate cancer are at risk for both overtreatment of low-risk disease and undertreatment of high-risk disease. Prostate cancer management decisions for older patients should be tailored based on an individual patient's health status, coexisting medical conditions, life expectancy, and tumor characteristics.

摘要

大多数被诊断患有前列腺癌的男性都是在晚年被诊断出来的。虽然局限性前列腺癌通常是一种惰性疾病,但老年男性更常被诊断为高危疾病,并且比年轻男性更容易死于前列腺癌。同时,在生命的后期几十年中,合并症也更为普遍,这可能会影响前列腺癌治疗的耐受性以及从积极治疗中获益的可能性。被诊断患有前列腺癌的老年男性既有过度治疗低危疾病的风险,也有治疗高危疾病不足的风险。对于老年患者,应根据患者的健康状况、合并症、预期寿命和肿瘤特征,对前列腺癌的管理决策进行个体化定制。

相似文献

1
Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.老年男性局限性前列腺癌的管理:高龄和合并症的意义。
Semin Radiat Oncol. 2012 Oct;22(4):284-94. doi: 10.1016/j.semradonc.2012.05.005.
2
Management of metastatic prostate cancer: the crucial role of geriatric assessment.转移性前列腺癌的管理:老年评估的关键作用。
BJU Int. 2008 Mar;101 Suppl 2:23-9. doi: 10.1111/j.1464-410X.2007.07486.x.
3
Management of prostate cancer in elderly men.老年男性前列腺癌的管理。
Semin Radiat Oncol. 2013 Jul;23(3):198-205. doi: 10.1016/j.semradonc.2013.01.007.
4
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).雄激素剥夺疗法作为局限性前列腺癌的主要治疗方法:来自前列腺癌战略泌尿学研究计划(CaPSURE)的数据。
Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799.
5
Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum.为老年前列腺癌男性进行个体化决策:在整个临床谱上平衡癌症控制与治疗后果。
Semin Oncol. 2011 Apr;38(2):309-25. doi: 10.1053/j.seminoncol.2011.01.011.
6
Management of localized prostate cancer in men over 65 years.65岁以上男性局限性前列腺癌的管理
Curr Opin Urol. 2009 May;19(3):309-14. doi: 10.1097/MOU.0b013e328329a303.
7
Prostate cancer in the elderly.老年前列腺癌
Urol Oncol. 2009 Nov-Dec;27(6):668-72. doi: 10.1016/j.urolonc.2009.07.015.
8
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.七十岁以上高危局限性前列腺癌男性治疗不足。
Eur Urol. 2015 Jul;68(1):53-8. doi: 10.1016/j.eururo.2014.12.026. Epub 2015 Mar 23.
9
Overtreatment of men with low-risk prostate cancer and significant comorbidity.对患有低危前列腺癌且合并症严重的男性进行过度治疗。
Cancer. 2011 May 15;117(10):2058-66. doi: 10.1002/cncr.25751. Epub 2010 Nov 29.
10
[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].[竞争性发病及其对预期寿命的影响:在局限性前列腺癌治疗决策中的评估与纳入]
Prog Urol. 2001 Dec;11(6):1195-204.

引用本文的文献

1
Time trends in the use of curative treatment in men 70 years and older with nonmetastatic prostate cancer.70 岁及以上非转移性前列腺癌男性患者的根治性治疗方法的使用时间趋势。
Acta Oncol. 2024 Mar 20;63:95-104. doi: 10.2340/1651-226X.2024.26189.
2
Co-morbidities in a Retrospective Cohort of Prostate Cancer Patients.前列腺癌患者回顾性队列中的合并症。
Ethn Dis. 2020 Apr 2;30(Suppl 1):185-192. doi: 10.18865/ed.30.S1.185. eCollection 2020.
3
Prostate Cancer in Male Seniors Part 2: Treatment.老年男性前列腺癌 第二部分:治疗
Fed Pract. 2015 Aug;32(Suppl 7):36S-40S.
4
Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making.前列腺癌幸存者在治疗决策中的参与感的种族和民族差异。
J Racial Ethn Health Disparities. 2018 Dec;5(6):1273-1283. doi: 10.1007/s40615-018-0475-0. Epub 2018 Mar 7.
5
Undiagnosed prostatic malignancy at the time of radical cystoprostatectomy after prior prostatic radiation therapy.在先前接受前列腺放疗后进行根治性膀胱前列腺切除术时发现的未确诊前列腺恶性肿瘤。
Urol Ann. 2016 Apr-Jun;8(2):151-6. doi: 10.4103/0974-7796.163797.
6
Quality of Life and Sexual Health in the Aging of PCa Survivors.前列腺癌幸存者老龄化过程中的生活质量与性健康
Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.
7
Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?个性化医疗、疾病预防与逆医疗法则:弊大于利?
Eur J Epidemiol. 2014 Jun;29(6):383-90. doi: 10.1007/s10654-014-9898-z. Epub 2014 Apr 12.
8
[Management of prostate cancer in the elderly].[老年前列腺癌的管理]
Urologe A. 2013 Jun;52(6):832-7. doi: 10.1007/s00120-013-3152-2.